Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/182219
Title: PHOSPHODIESTERASE INHIBITORS DESIGN SYNTHESIS AND 3D QSAR STUDIES OF PDE4B INHIBITORY BENZAZOLES WITH ANTI INFLAMMATORY AND BRONCHODILATORY ACTIVITY
Researcher: Naga Srinivas Tripuraneni
Guide(s): Afzal Azam, Md.
Keywords: PDE4B, PDE4D, benzazoles, enzyme inhibitions assays, anti-inflammatory, bronchodilatory.
University: JSS University
Completed Date: 2017
Abstract: quotOBJECTIVE: Some novel chemical entities bearing benzazole scaffold(s) were designed, synthesized and were evaluated by in vitro and in vivo protocols as selective PDE4B enzyme inhibitors. newlineMETHODS: The molecules were designed by in silico methods. The designed compounds were synthesized and characterized. All the compounds were evaluated for their potency to inhibit PDE4B and PDE4D enzymes using commercial assay kits. The molecules having two to four fold selectivity for PDE4B enzyme over PDE4D enzyme were subjected to pharmacological screening. Acute oral toxicity studies and anti-inflammatory activity testing screening were perfpormed. The compounds showing significant anti-inflammatory activity were evaluated for emetogenic potentialand bronchodilatory activity. newlineResults: A virtual library of 750 molecules was designed by fragment based drug designing and pharmacophore modeling, basing on the outcomes, novel molecules having selectivity for PDE4B over PDE4D in in silico were designed. The designed compounds were synthesised with moderate yields (58-72%) and characterized. PDE4B and PDE4D enzyme inhibition assays were performed for sixteen molecules and ten molecules were found to be selective for PDE4B over PDE4D. These molecules were found to be non-toxic in the acute oral toxicity studies performed as per OECD-423 guidelines. Significant anti-inflammatory activity was observed for compounds in some compounds when compared with the standard drug diclofenac. These molecules were also found to be less emetogenic than cisplatin. These compounds were evaluated for their bronchodilatory activity. One compound showed significant bronchodilatory activity, others showed moderate bronchodilatory activity. newlineConclusion: Benzazole scaffolds were designed and evaluated as selective PDE4B enzyme inhibitors. Compounds were found to be non-toxic, and were found possess significant anti-inflammatory activity, less emetogenic potential and moderate bronchodilatory activity. newlinequot newline
Pagination: I-X, 1-171p
URI: http://hdl.handle.net/10603/182219
Appears in Departments:College of Pharmacy

Files in This Item:
File Description SizeFormat 
10.materials and methods.pdfAttached File628.17 kBAdobe PDFView/Open
11.results an discussion.pdf5.39 MBAdobe PDFView/Open
12.sumary and conclusion.pdf427.67 kBAdobe PDFView/Open
13.references.pdf694.8 kBAdobe PDFView/Open
14a.iaec-annexure.pdf89.88 kBAdobe PDFView/Open
14.annexures.pdf406.37 kBAdobe PDFView/Open
14.bpublcations-annexure.pdf1.1 MBAdobe PDFView/Open
1.title.pdf244.94 kBAdobe PDFView/Open
2.certificates.pdf316.79 kBAdobe PDFView/Open
3.acknowledgement.pdf216.58 kBAdobe PDFView/Open
4.abbreviations, tables and figures.pdf357.3 kBAdobe PDFView/Open
5.table of contents.pdf163.06 kBAdobe PDFView/Open
6.abstract.pdf259.67 kBAdobe PDFView/Open
7.plan of work.pdf355.94 kBAdobe PDFView/Open
8.introduction.pdf679.74 kBAdobe PDFView/Open
9.literature review.pdf611.36 kBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: